In mice, expression of activated YAP and AKT in hepatocytes is sufficient to induce cholangiocarcinoma dependent on AKT/mTOR signaling, which likely cooperates with YAP in tumorigenesis and possibly promotes YAP activity (Zhang et al., 2017; Zhao et al., 2018). The gene discussed is YAP1; the disease is cholangiocarcinoma.